Sangamo Therapeutics, Inc.SGMONASDAQ
LOADING
|||
Switch Symbol:
Operating Income Scaling
Trending higher, above historical average, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-103.97M
↑ 17% above average
Average (9y)
$-125.02M
Historical baseline
Range
High:$-46.86M
Low:$-274.00M
CAGR
+9.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-103.97M | +62.1% |
| 2023 | $-274.00M | -36.1% |
| 2022 | $-201.28M | -9.8% |
| 2021 | $-183.34M | -41.5% |
| 2020 | $-129.55M | -23.2% |
| 2019 | $-105.18M | -36.3% |
| 2018 | $-77.15M | -36.9% |
| 2017 | $-56.36M | +22.3% |
| 2016 | $-72.56M | -54.9% |
| 2015 | $-46.86M | - |